tonic-life-communications

Media

Janssen Submits Applications Requesting Approval Of STELARA® In U.S. And Europe For Treatment Of Active Psoriatic Arthritis

Media

Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis

Media

Janssen Submits Applications Requesting Approval Of SIMPONI® In U.S. And Europe For Treatment Of Moderately To Severely Active Ulcerative Colitis

Media

Resultados positivos de los primeros ensayos clínicos humanos de un sistema artificial de páncreas

Media

Neuronetics, Inc. recibe la aprobación de CE Mark para la terapia NeuroStar TMS

Media

Résultats positifs des premiers essais cliniques d'un système de pancréas artificiel de première génération : le signe d'un progrès significatif pour des millions de personnes atteintes du diabète de type 1

Media

Neuronetics, Inc. obtient le marquage CE pour le système NeuroStar TMS Therapy

Media

Positive Results from First Human Clinical Trials of a First-Generation Artificial Pancreas System is Significant Step Forward for Millions with Type 1 Diabetes

Media

Neuronetics, Inc. Receives CE Mark Approval for NeuroStar TMS Therapy